TPN171H ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

---

臨床試験数 : 1,205 /  薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05208814 (ClinicalTrials.gov)	March 31, 2022	29/12/2021	a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects	a Parallel, Open, Single-dose Administration Phase I Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects	Pulmonary Arterial Hypertension;Erectile Dysfunction	Drug: TPN171H single dose	Vigonvita Life Sciences	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	Completed	18 Years	70 Years	All	16	Phase 1	China
2	NCT05185011 (ClinicalTrials.gov)	December 16, 2021	22/12/2021	Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function	A Phase I Clinical Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild Liver Insufficiency, Moderate Liver Insufficiency and Normal Liver Function	Erectile Dysfunction;Pulmonary Arterial Hypertension	Drug: TPN171H	Vigonvita Life Sciences	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	Completed	18 Years	65 Years	All	24	Phase 1	China